NMES to Improve Hip Abductor Strength and Balance

NCT ID: NCT02992275

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-06-01

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the addition of neuromuscular electrical stimulation (NMES) on the hip abductors during strength training and a fall prevention program for improving muscle strength and improving balance. All individuals in this study will receive NMES to their hip abductors and will participate in a fall reduction program.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Falls are a leading cause of disability in older adults. Decreased lower extremity muscle mass and strength contribute to balance and mobility limitations. Our more recent work also suggests that in addition to the traditional targets of muscle mass of the thigh and leg muscles, dysfunction of the hip abductors may contribute to balance and mobility limitations resulting in increased fall risk. Older adults with impaired hip abductor muscles demonstrate increased amounts of intramuscular fat (IMAT) in and around the muscles, decreased hip abductor strength, lower balance scores, increased gait variability (a predictor of future falls), and poor stepping mechanics when recovering from a balance perturbation. Increased IMAT and muscle dysfunction of the hip abductors may contribute to poor hip abductor muscle recruitment and make changing these muscle during a traditional intervention difficult. Neuromuscular electrical stimulation (NMES) is one method to improve muscle mass, strength and quality in older adults, but has not traditionally been used on the hip abductors. We propose that a targeted multimodality balance intervention (MMBI) focused on the lateral and diagonal stepping and hip abductor strengthening when combined with NMES will result in improvements in mobility and balance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postural Balance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NMES + MMBI

Neuromuscular electrical stimulation applied to hip abductors along with participation in a multi-modality balance intervention

Group Type EXPERIMENTAL

Neuromuscular electrical stimulation (NMES)

Intervention Type OTHER

Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 24 weeks

Multi-Modality Balance Intervention (MMBI)

Intervention Type OTHER

Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 24 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuromuscular electrical stimulation (NMES)

Participants will receive NMES to the hip abductors while performing strength training 3 times per week for 24 weeks

Intervention Type OTHER

Multi-Modality Balance Intervention (MMBI)

Participants will attend a group balance class that focuses on movement and obstacle negotiation 3 times per week for 24 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Mobility and balance limitations as demonstrated by a self-reported fall within the past year or requiring greater than 8 seconds to complete the 4-square step test

\-

Exclusion Criteria

1. Cardiovascular Risks: Poorly controlled hypertension (\>160/100); or patient report of: symptomatic angina at rest or during exercise, syncope without known resolution of cause, or a significant coronary event (such as a MI) in the past six months
2. COPD requiring home oxygen
3. Contraindications to resistance training, including a self-reported history of intracranial or retinal bleeding in the last year or Diabetes with active proliferative retinopathy
4. Patient report of significant spinal stenosis that would limit participation in the exercise intervention
5. Non-ambulatory mobility status or a transtibial or transfemoral amputation
6. Dementia (on medical record review or mini-mental status exam score \<24).
7. Other severe medical illness or condition that would preclude safe participation in the study as determined by the study team
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Baltimore VA Medical Center

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Odessa Addison

Research Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Les Katzel, MD, PhD

Role: STUDY_DIRECTOR

Director Baltmore GRECC

Odessa Addison, DPT, PhD

Role: PRINCIPAL_INVESTIGATOR

Research Scientist

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Baltimore VA Medical Center

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HP-00072630

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AB Gait Estim Neurophysiology
NCT06430164 RECRUITING NA
Stimulation-based Therapy to Improve Balance in DCM
NCT07298460 NOT_YET_RECRUITING PHASE1/PHASE2